Vollins James 4
4 · Eiger BioPharmaceuticals, Inc. · Filed May 2, 2023
Insider Transaction Report
Form 4
Vollins James
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2023-04-30+120,000→ 120,000 totalExercise: $1.03Exp: 2033-04-29→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option vests as to twenty-five percent of the shares upon the one-year anniversary of April 12, 2023, and in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service status as of each such date.